Type:Notice
Citation:89 FR 102954
Reading Time:about a minute or two
Leading Pharma LLC has applied to register as an importer of controlled substances. This application is for research and development purposes, aiming toward creating a new pharmaceutical product that is pending approval by the Food and Drug Administration (FDA). Interested parties can submit comments or request a hearing regarding this application, with a deadline of January 17, 2025. The Drug Enforcement Administration (DEA) will approve the application only if it meets specific legal criteria.
Simple Explanation
Leading Pharma LLC wants permission to bring special medicines into the country to make new drugs, but people can say what they think about this until January 17, 2025. The government will check if it's okay for them to do this.